WORLD'S FIRST INTRANASAL VACCINE
iNCOVACC
iNCOVACC® is the world’s first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule and heterologous booster dose.
A user-friendly application that requires no trained health care professionals.
The Government of India partly funded product development and clinical trials through the Department of Biotechnology’s COVID Suraksha Program.